Hyperekplexia: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|A rare neurological disorder characterized by an exaggerated startle response}} | {{Short description|A rare neurological disorder characterized by an exaggerated startle response}} | ||
{{Use dmy dates|date=October 2023}} | {{Use dmy dates|date=October 2023}} | ||
{{Infobox medical condition (new) | |||
| name = Hyperekplexia | |||
| synonyms = Startle disease, exaggerated startle reflex | |||
| image = PDB 1mot EBI.jpg | |||
| caption = Molecular structure of glycine receptor affected in some forms of hyperekplexia | |||
| pronounce = | |||
| field = [[Neurology]], [[Genetics]] | |||
| meshName = Hyperekplexia | |||
| meshNumber = D020165 | |||
| symptoms = Exaggerated startle reflex, muscle stiffness (hypertonia), sudden falls, apnea (in infants) | |||
| complications = Risk of injury due to falls, breathing difficulties in neonates | |||
| onset = Typically at birth or in early infancy | |||
| duration = Lifelong, may improve with age | |||
| types = Familial hyperekplexia, sporadic hyperekplexia | |||
| causes = Mutations in genes encoding glycine receptor components (e.g., [[GLRA1]], [[GLRB]], [[SLC6A5]], [[GPHN]]) | |||
| risks = Inherited in an [[autosomal dominant]] or [[autosomal recessive]] pattern | |||
| diagnosis = Clinical examination, genetic testing, electromyography (EMG) | |||
| differential = [[Epilepsy]], [[infantile spasms]], [[startle epilepsy]], [[tetanus]] | |||
| prevention = None | |||
| treatment = Supportive care, physical therapy, safety measures | |||
| medication = [[Clonazepam]] (commonly used to reduce startle response) | |||
| prognosis = Varies; often improves with age, though startle response may persist | |||
| frequency = Rare | |||
| deaths = Rare, typically due to apnea or falls in early infancy | |||
}} | |||
'''Hyperekplexia''' is a rare [[neurological disorder]] characterized by an exaggerated [[startle reflex]]. This condition is also known as "startle disease" or "stiff baby syndrome" when it presents in infants. The disorder is primarily genetic and can manifest in both hereditary and sporadic forms. | '''Hyperekplexia''' is a rare [[neurological disorder]] characterized by an exaggerated [[startle reflex]]. This condition is also known as "startle disease" or "stiff baby syndrome" when it presents in infants. The disorder is primarily genetic and can manifest in both hereditary and sporadic forms. | ||
| Line 32: | Line 57: | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
== External links == | |||
{{Medical resources | |||
| DiseasesDB = 7208 | |||
| ICD10 = {{ICD10|G|25|8||g|25}} | |||
| ICD9 = {{ICD9|759.89}} | |||
| ICDO = | |||
| OMIM = 149400 | |||
| OMIM_mult = {{OMIM2|138491}} {{OMIM2|138492}} {{OMIM2|300429}} {{OMIM2|300607}} {{OMIM2|603930}} {{OMIM2|604159}} | |||
| MedlinePlus = | |||
| eMedicineSubj = | |||
| eMedicineTopic = | |||
| GeneReviewsNBK = NBK1260 | |||
| GeneReviewsName = Hyperekplexia | |||
}} | |||
*[https://www.ncbi.nlm.nih.gov/books/NBK1260/ GeneReview/NIH/UW entry on Hyperekplexia] | |||
{{stub}} | |||
[[Category:Rare diseases]] | |||
[[Category:Neurological disorders]] | |||
[[Category:Reflexes]] | |||
[[Category:Rare diseases]] | |||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
Latest revision as of 02:55, 23 March 2025
A rare neurological disorder characterized by an exaggerated startle response
| Hyperekplexia | |
|---|---|
| File:PDB 1mot EBI.jpg | |
| Synonyms | Startle disease, exaggerated startle reflex |
| Pronounce | |
| Field | Neurology, Genetics |
| Symptoms | Exaggerated startle reflex, muscle stiffness (hypertonia), sudden falls, apnea (in infants) |
| Complications | Risk of injury due to falls, breathing difficulties in neonates |
| Onset | Typically at birth or in early infancy |
| Duration | Lifelong, may improve with age |
| Types | Familial hyperekplexia, sporadic hyperekplexia |
| Causes | Mutations in genes encoding glycine receptor components (e.g., GLRA1, GLRB, SLC6A5, GPHN) |
| Risks | Inherited in an autosomal dominant or autosomal recessive pattern |
| Diagnosis | Clinical examination, genetic testing, electromyography (EMG) |
| Differential diagnosis | Epilepsy, infantile spasms, startle epilepsy, tetanus |
| Prevention | None |
| Treatment | Supportive care, physical therapy, safety measures |
| Medication | Clonazepam (commonly used to reduce startle response) |
| Prognosis | Varies; often improves with age, though startle response may persist |
| Frequency | Rare |
| Deaths | Rare, typically due to apnea or falls in early infancy |
Hyperekplexia is a rare neurological disorder characterized by an exaggerated startle reflex. This condition is also known as "startle disease" or "stiff baby syndrome" when it presents in infants. The disorder is primarily genetic and can manifest in both hereditary and sporadic forms.
Signs and Symptoms[edit]
Individuals with hyperekplexia exhibit an abnormal startle response to unexpected stimuli, such as loud noises or sudden movements. This response is often accompanied by a temporary muscle stiffness or rigidity, which can lead to falls and injuries. In infants, the condition may present as excessive muscle tone and a tendency to startle easily.
Infantile Hyperekplexia[edit]
In newborns, hyperekplexia can be identified by a pronounced startle response and hypertonia, which is an increased muscle tone. Affected infants may appear stiff and have difficulty with normal movements. The exaggerated startle reflex can interfere with feeding and breathing, leading to potential complications.
Adult Hyperekplexia[edit]
In adults, the symptoms of hyperekplexia may include sudden falls due to the startle response, which can occur without warning. The condition can also cause anxiety and social withdrawal due to the unpredictability of the startle episodes.
Causes[edit]
Hyperekplexia is often caused by mutations in the GLRA1 gene, which encodes the alpha-1 subunit of the glycine receptor. Glycine is an important neurotransmitter in the central nervous system, and its receptor plays a crucial role in inhibitory neurotransmission. Mutations in this gene can disrupt normal receptor function, leading to the symptoms of hyperekplexia.
Diagnosis[edit]
The diagnosis of hyperekplexia is based on clinical evaluation, family history, and genetic testing. Electromyography (EMG) and nerve conduction studies may be used to assess the startle response and muscle activity. Genetic testing can confirm mutations in the GLRA1 gene or other related genes.
Treatment[edit]
Treatment for hyperekplexia often involves the use of medications to reduce the startle response and muscle stiffness. Clonazepam, a benzodiazepine, is commonly prescribed to help manage symptoms. In some cases, other medications such as valproic acid or carbamazepine may be used.
Prognosis[edit]
The prognosis for individuals with hyperekplexia varies. With appropriate treatment, many individuals can manage their symptoms effectively and lead relatively normal lives. However, the risk of injury from falls remains a concern, and ongoing medical management is often necessary.
